Susquehanna International Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.06M | Buy |
995,663
+556,164
| +127% | +$2.41M | ﹤0.01% | 5235 |
|
|
2025
Q4 | $1.56M | Sell |
439,499
-164,319
| -27% | -$1.01M | ﹤0.01% | 6148 |
|
|
2025
Q3 | $5.37M | Sell |
603,818
-2,849
| -0.5% | -$28.9K | ﹤0.01% | 3966 |
|
|
2025
Q2 | $5.59M | Sell |
606,667
-180,433
| -23% | -$1.54M | ﹤0.01% | 3767 |
|
|
2025
Q1 | $6.75M | Sell |
787,100
-347,638
| -31% | -$3.28M | ﹤0.01% | 3108 |
|
|
2024
Q4 | $12.2M | Buy |
1,134,738
+896,321
| +376% | +$6.89M | ﹤0.01% | 2416 |
|
|
2024
Q3 | $1.35M | Sell |
238,417
-26,018
| -10% | -$150K | ﹤0.01% | 6145 |
|
|
2024
Q2 | $1.12M | Sell |
264,435
-37,625
| -12% | -$152K | ﹤0.01% | 6325 |
|
|
2024
Q1 | $1.54M | Sell |
302,060
-419,293
| -58% | -$2.36M | ﹤0.01% | 5943 |
|
|
2023
Q4 | $6.72M | Buy |
721,353
+275,440
| +62% | +$1.9M | ﹤0.01% | 3227 |
|
|
2023
Q3 | $2.92M | Sell |
445,913
-187,726
| -30% | -$1.49M | ﹤0.01% | 4431 |
|
|
2023
Q2 | $5.15M | Buy |
633,639
+24,845
| +4% | +$213K | ﹤0.01% | 3478 |
|
|
2023
Q1 | $5.22M | Buy |
608,794
+233,906
| +62% | +$2.33M | ﹤0.01% | 3408 |
|
|
2022
Q4 | $3.47M | Buy |
374,888
+12,571
| +3% | +$134K | ﹤0.01% | 3790 |
|
|
2022
Q3 | $3.74M | Buy |
362,317
+81,160
| +29% | +$857K | ﹤0.01% | 3652 |
|
|
2022
Q2 | $2.81M | Buy |
281,157
+859
| +0.3% | +$8.14K | ﹤0.01% | 4202 |
|
|
2022
Q1 | $3.45M | Sell |
280,298
-263,725
| -48% | -$3.24M | ﹤0.01% | 4355 |
|
|
2021
Q4 | $9.43M | Buy |
544,023
+51,840
| +11% | +$985K | ﹤0.01% | 2807 |
|
|
2021
Q3 | $8.84M | Sell |
492,183
-193,833
| -28% | -$3.86M | ﹤0.01% | 3048 |
|
|
2021
Q2 | $15.7M | Buy |
686,016
+655,260
| +2,131% | +$9.71M | ﹤0.01% | 2322 |
|
|
2021
Q1 | $460K | Sell |
30,756
-110,825
| -78% | -$1.21M | ﹤0.01% | 9674 |
|
|
2020
Q4 | $765K | Sell |
141,581
-163,352
| -54% | -$861K | ﹤0.01% | 7319 |
|
|
2020
Q3 | $1.39M | Buy |
304,933
+87,229
| +40% | +$375K | ﹤0.01% | 5342 |
|
|
2020
Q2 | $1.07M | Sell |
217,704
-25,148
| -10% | -$95K | ﹤0.01% | 5765 |
|
|
2020
Q1 | $765K | Buy |
242,852
+98,325
| +68% | +$343K | ﹤0.01% | 5983 |
|
|
2019
Q4 | $374K | Sell |
144,527
-12,514
| -8% | -$32.8K | ﹤0.01% | 7560 |
|
|
2019
Q3 | $496K | Sell |
157,041
-81,517
| -34% | -$235K | ﹤0.01% | 7326 |
|
|
2019
Q2 | $803K | Sell |
238,558
-98,967
| -29% | -$307K | ﹤0.01% | 6182 |
|
|
2019
Q1 | $1.03M | Buy |
337,525
+212,588
| +170% | +$508K | ﹤0.01% | 4994 |
|
|
2018
Q4 | $195K | Sell |
124,937
-79,062
| -39% | -$179K | ﹤0.01% | 7773 |
|
|
2018
Q3 | $557K | Buy |
203,999
+27,339
| +15% | +$77.1K | ﹤0.01% | 6317 |
|
|
2018
Q2 | $463K | Buy |
176,660
+102,177
| +137% | +$285K | ﹤0.01% | 6942 |
|
|
2018
Q1 | $206K | Sell |
74,483
-189,884
| -72% | -$537K | ﹤0.01% | 8276 |
|
|
2017
Q4 | $851K | Buy |
264,367
+27,872
| +12% | +$110K | ﹤0.01% | 5557 |
|
|
2017
Q3 | $979K | Sell |
236,495
-28,536
| -11% | -$127K | ﹤0.01% | 5309 |
|
|
2017
Q2 | $1.41M | Sell |
265,031
-8,881
| -3% | -$51.3K | ﹤0.01% | 4550 |
|
|
2017
Q1 | $1.57M | Sell |
273,912
-56,557
| -17% | -$292K | ﹤0.01% | 4174 |
|
|
2016
Q4 | $1.31M | Buy |
330,469
+207,327
| +168% | +$739K | ﹤0.01% | 4961 |
|
|
2016
Q3 | $447K | Buy |
123,142
+102,685
| +502% | +$432K | ﹤0.01% | 6280 |
|
|
2016
Q2 | $125K | Sell |
20,457
-116,798
| -85% | -$564K | ﹤0.01% | 7914 |
|
|
2016
Q1 | $673K | Buy |
137,255
+39,537
| +40% | +$174K | ﹤0.01% | 5871 |
|
|
2015
Q4 | $544K | Buy |
+97,718
| New | +$695K | ﹤0.01% | 6594 |
|
Other funds holding AVXL
VCM
SF
VPM
